Literature DB >> 3014541

Expression of the protein encoded by the 3' open reading frame of human T-cell lymphotropic virus type III in bacteria: demonstration of its immunoreactivity with human sera.

G Franchini, M Robert-Guroff, F Wong-Staal, J Ghrayeb, I Kato, T W Chang, N T Chang.   

Abstract

The genome of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV), the infectious agent etiologically associated with the acquired immunodeficiency syndrome, contains, in addition to the genes for the polymerase, core, and envelope proteins, several open reading frames. To investigate whether the 3' open reading frame (3' orf) located between the envelope gene and the 3' long terminal repeat is a gene expressed in vivo in infected individuals, we inserted a fragment of 3' orf in a prokaryotic expression vector. The protein product synthesized in bacteria was purified and allowed to react with sera from individuals infected with human T-cell lymphotropic virus type III as indicated by seropositivity for other viral proteins. Two-thirds of the sera, regardless of the clinical status of the individuals, reacted with the purified protein indicating that 3' orf is a viral gene the product of which is immunogenic in vivo. A polyclonal rabbit antiserum reacting against the 3' orf gene product was obtained by serial injection of rabbits with the purified bacterial protein. The antiserum recognized a 27-kDa protein in the human T-cell lymphotropic virus type III-infected lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014541      PMCID: PMC323935          DOI: 10.1073/pnas.83.14.5282

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

2.  Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.

Authors:  J Sodroski; R Patarca; C Rosen; F Wong-Staal; W Haseltine
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  T4 positive human neoplastic cell lines susceptible to and permissive for HTLV-III.

Authors:  M Popovic; E Read-Connole; R C Gallo
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321

5.  Human T-cell lymphotropic virus type III (HTLV-III) core antigens: synthesis in Escherichia coli and immunoreactivity with human sera.

Authors:  J Ghrayeb; I Kato; S McKinney; J J Huang; P K Chanda; D D Ho; M G Sarangadharan; T W Chang; N T Chang
Journal:  DNA       Date:  1986-04

6.  Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

Authors:  M G Sarngadharan; M Popovic; L Bruch; J Schüpbach; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

7.  Molecular cloning and characterization of the HTLV-III virus associated with AIDS.

Authors:  B H Hahn; G M Shaw; S K Arya; M Popovic; R C Gallo; F Wong-Staal
Journal:  Nature       Date:  1984 Nov 8-14       Impact factor: 49.962

8.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

9.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency.

Authors:  M S Gottlieb; R Schroff; H M Schanker; J D Weisman; P T Fan; R A Wolf; A Saxon
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  10 in total

1.  Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication.

Authors:  P A Luciw; C Cheng-Mayer; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

2.  Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein.

Authors:  B K Felber; C M Drysdale; G N Pavlakis
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

3.  Pattern of transcription of the genome of equine infectious anemia virus.

Authors:  S Noiman; A Yaniv; L Sherman; S R Tronick; A Gazit
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

4.  Antibodies to recombinant HIV-1 vif, tat, and nef proteins in human sera.

Authors:  U Wieland; J E Kühn; C Jassoy; H Rübsamen-Waigmann; V Wolber; R W Braun
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

5.  Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection.

Authors:  R S Smith; R B Naso; J Rosen; A Whalley; Y L Hom; K Hoey; C J Kennedy; J A McCutchan; S A Spector; D D Richman
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

6.  Serological markers as prognostic criteria for the course of HIV infection.

Authors:  A Kleinschmidt; A Matuschke; F D Goebel; V Erfle; R Hehlmann
Journal:  Infection       Date:  1991       Impact factor: 3.553

7.  3'-orf and sor genes of human immunodeficiency virus: in vitro transcription-translation and immunoreactive domains.

Authors:  S K Arya
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines.

Authors:  A Ranki; A Lagerstedt; V Ovod; E Aavik; K J Krohn
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

9.  Fine mapping of HIV-1 Nef-epitopes by monoclonal antibodies.

Authors:  H Siakkou; S Jahn; N Kienzle; R Ulrich; C Grötzinger; T Schneider; B Kohleisen; G Pauli; R Spohn; G Jung
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 10.  The activity of Nef on HIV-1 infectivity.

Authors:  Stéphane Basmaciogullari; Massimo Pizzato
Journal:  Front Microbiol       Date:  2014-05-20       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.